MFAP2 promotes epithelial–mesenchymal transition in gastric cancer cells by activating TGF-β/SMAD2/3 signaling pathway

Overview of attention for article published in OncoTargets and therapy, July 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 29 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 40 publications that cite this research output.

40

The most recent citing publications are shown below. View all 40 publications that cite this research output on Dimensions.

The use of MFAP2 for diagnosis, prognosis and immunotherapy of triple-negative breast cancer.

Article in American Journal of Translational Research (January 2024)

Combined signature of G protein-coupled receptors and tumor microenvironment provides a prognostic and therapeutic biomarker for skin cutaneous melanoma

Article in Journal of Cancer Research and Clinical Oncology (November 2023)

MFAP2 promotes HSCs activation through FBN1/TGF‐β/Smad3 pathway

Article in Journal of Cellular and Molecular Medicine (August 2023)